RNase P Inhibitors Identified as Aggregators.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
16 07 2021
Historique:
pubmed: 12 5 2021
medline: 10 8 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

RNase P is an essential enzyme responsible for tRNA 5'-end maturation. In most bacteria, the enzyme is a ribonucleoprotein consisting of a catalytic RNA subunit and a small protein cofactor termed RnpA. Several studies have reported small-molecule inhibitors directed against bacterial RNase P that were identified by high-throughput screenings. Using the bacterial RNase P enzymes from Thermotoga maritima, Bacillus subtilis, and Staphylococcus aureus as model systems, we found that such compounds, including RNPA2000 (and its derivatives), iriginol hexaacetate, and purpurin, induce the formation of insoluble aggregates of RnpA rather than acting as specific inhibitors. In the case of RNPA2000, aggregation was induced by Mg

Identifiants

pubmed: 33972249
pii: AAC.00300-21
doi: 10.1128/AAC.00300-21
pmc: PMC8284443
doi:

Substances chimiques

RNA, Bacterial 0
Ribonuclease P EC 3.1.26.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0030021

Références

J Med Chem. 2002 Apr 11;45(8):1712-22
pubmed: 11931626
Biochemistry. 1997 Jul 29;36(30):9101-8
pubmed: 9230042
Science. 1998 May 1;280(5364):752-5
pubmed: 9563955
Nature. 2014 Sep 25;513(7519):481-3
pubmed: 25254460
ACS Chem Biol. 2014 Aug 15;9(8):1788-98
pubmed: 24901212
Biochemistry. 2001 Mar 6;40(9):2777-89
pubmed: 11258888
FEBS Lett. 2017 Nov;591(21):3523-3535
pubmed: 28960276
Chembiochem. 2003 Oct 6;4(10):1049-56
pubmed: 14523923
J Med Chem. 2003 Sep 25;46(20):4265-72
pubmed: 13678405
Molecules. 2018 Jul 27;23(8):
pubmed: 30060466
ChemMedChem. 2017 Sep 7;12(17):1419-1423
pubmed: 28745428
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Cell. 1983 Dec;35(3 Pt 2):849-57
pubmed: 6197186
Antimicrob Agents Chemother. 2015 Apr;59(4):2016-28
pubmed: 25605356
Nucleic Acids Res. 2019 Jul 9;47(12):6425-6438
pubmed: 30997498
J Med Chem. 2003 Oct 9;46(21):4477-86
pubmed: 14521410
J Med Chem. 2015 Sep 10;58(17):7076-87
pubmed: 26295373
PLoS Pathog. 2011 Feb 10;7(2):e1001287
pubmed: 21347352
RNA. 2018 Jan;24(1):1-5
pubmed: 28971852
Nucleic Acids Res. 1998 Jul 1;26(13):3090-6
pubmed: 9628904
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11121-11126
pubmed: 29073018
Nucleic Acids Res. 2001 Feb 15;29(4):880-5
pubmed: 11160919
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9268-73
pubmed: 9689069
RNA Biol. 2015;12(6):658-74
pubmed: 25997461
J Med Chem. 2008 Feb 14;51(3):574-80
pubmed: 18181566
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6155-60
pubmed: 10339557
J Med Chem. 2003 Apr 10;46(8):1478-83
pubmed: 12672248
Nat Struct Biol. 2001 Jun;8(6):510-4
pubmed: 11373618
Nucleic Acids Res. 2010 Dec;38(22):7885-94
pubmed: 20716516
Nucleic Acids Res. 2007;35(6):2060-73
pubmed: 17355991
RNA. 2016 Nov;22(11):1699-1709
pubmed: 27604960
J Bacteriol. 2006 Oct;188(19):6816-23
pubmed: 16980484
Toxicology. 2006 Nov 10;228(1):24-32
pubmed: 16989930
Cell. 2008 Oct 31;135(3):462-74
pubmed: 18984158
J Bacteriol. 2011 Oct;193(19):5520-6
pubmed: 21764917
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1127-1131
pubmed: 29463447
Nat Protoc. 2006;1(2):550-3
pubmed: 17191086
J Med Chem. 2017 Mar 23;60(6):2165-2168
pubmed: 28244745
J Biol Chem. 2006 Oct 13;281(41):30613-20
pubmed: 16901906
J Bacteriol. 1990 Nov;172(11):6316-22
pubmed: 1699929
ACS Chem Biol. 2018 Jan 19;13(1):36-44
pubmed: 29202222
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
pubmed: 21948594
J Cheminform. 2016 May 28;8:29
pubmed: 27239230
Nat Chem Biol. 2005 Aug;1(3):146-8
pubmed: 16408018
J Med Chem. 2009 Apr 9;52(7):2067-75
pubmed: 19281222
Nucleic Acids Res. 2014 Nov 10;42(20):e159
pubmed: 25249623
J Med Chem. 2010 Feb 11;53(3):1004-14
pubmed: 20041667
J Am Chem Soc. 2008 Jul 23;130(29):9606-12
pubmed: 18588298
J Comput Aided Mol Des. 2007 Jan-Mar;21(1-3):139-44
pubmed: 17340041
J Mol Biol. 2000 Jan 7;295(1):105-15
pubmed: 10623511
Biomolecules. 2016 Sep 08;6(3):
pubmed: 27618117
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4678-83
pubmed: 12682299
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7497-502
pubmed: 12799461
Future Med Chem. 2010 Oct;2(10):1529-46
pubmed: 21426147
FEBS Lett. 2002 Jan 30;511(1-3):107-12
pubmed: 11821058
ACS Chem Biol. 2012 Aug 17;7(8):1429-35
pubmed: 22625864
Bioorg Med Chem. 1999 Sep;7(9):1979-91
pubmed: 10530947
Prog Mol Biol Transl Sci. 2009;85:319-68
pubmed: 19215776
Chembiochem. 2012 Oct 15;13(15):2270-6
pubmed: 22976545
Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1234-6
pubmed: 12077454
J Med Chem. 2013 Mar 28;56(6):2406-14
pubmed: 23437772

Auteurs

Isabell Schencking (I)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Eva M Schäfer (EM)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

J H William Scanlan (JHW)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.
Zentrum für Tumor- und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.

Benjamin M Wenzel (BM)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Rolf E Emmerich (RE)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Torsten Steinmetzer (T)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Wibke E Diederich (WE)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.
Zentrum für Tumor- und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.

Martin Schlitzer (M)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Roland K Hartmann (RK)

Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH